Eagle Pharmaceuticals, Inc. ( NASDAQ:EGRX – Get Rating ) was the target of a significant drop in short interest in the month of March. As of March 31st, there was short interest totalling 939,300 shares, a drop of 7.9% from the March 15th total of 1,020,000 shares. Approximately 8.3% of the company's stock are short sold. Based on an average daily trading volume, of 169,900 shares, the short-interest ratio is presently 5.5 days. Eagle Pharmaceuticals Trading Down 0.8 % Shares of Eagle Pharmaceuticals stock traded down $0.

https://www.dailypolitical.com/2023/04/21/short-interest-in-eagle-pharmaceuticals-inc-nasdaqegrx-declines-by-7-9.html

#dailypolitical